⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
globenewswire.com
UTHR
GOSS
JNJ
MRK
LQDA
Gossamer Bio to Present at Cantor Global Healthcare Conference
businesswire.com
GOSS
Form 8-K
sec.gov
GOSS
Form 8-K
sec.gov
GOSS
Lifshitz Law PLLC Announces Investigations of United Homes Group, Inc. (NASDAQ: UHG), Upstart Holdings, Inc. (NASDAQ: UPST), Medpace Holdings, Inc. (NASDAQ: MEDP), and Gossamer Bio, Inc. (NASDAQ: GOSS)
accessnewswire.com
UHG
UPST
MEDP
GOSS
Form 8-K
sec.gov
GOSS
Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval
businesswire.com
GOSS
Form 8-K
sec.gov
GOSS
Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update
businesswire.com
GOSS
Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm
prnewswire.com
GOSS